Carlson College of Veterinary Medicine

S. Mukherjee, Petrofsky, M., Yaraei, K., Bermudez, L. E., and Cangelosi, G. A., “The white morphotype of Mycobacterium avium-intracellulare is common in infected humans and virulent in infection models.”, The Journal of infectious diseases, vol. 184, no. 11, pp. 1480-4, 2001.

F. J. Sangari, Bächli, M., Bermudez, L. E., and Bodmer, T., “Characterization of IS666, a newly described insertion element of Mycobacterium avium.”, Microbial & comparative genomics, vol. 5, no. 4, pp. 181-8, 2000.

L. E. Bermudez, Nash, K., Petrofsky, M., Young, L. S., and Inderlied, C. B., “Clarithromycin-resistant mycobacterium avium is still susceptible to treatment with clarithromycin and is virulent in mice.”, Antimicrobial agents and chemotherapy, vol. 44, no. 10, pp. 2619-22, 2000.

N. Mohagheghpour, van Vollenhoven, A., Goodman, J., and Bermudez, L. E., “Interaction of Mycobacterium avium with human monocyte-derived dendritic cells.”, Infection and immunity, vol. 68, no. 10, pp. 5824-9, 2000.

H. S. Wu, Kolonoski, P., Chang, Y. Y., and Bermudez, L. E., “Invasion of the brain and chronic central nervous system infection after systemic Mycobacterium avium complex infection in mice.”, Infection and immunity, vol. 68, no. 5, pp. 2979-84, 2000.

L. E. Bermudez, Wagner, D., and Sosnowska, D., “Mechanisms of Mycobacterium avium pathogenesis.”, Archivum immunologiae et therapiae experimentalis, vol. 48, no. 6, pp. 521-7, 2000.

L. E. Bermudez and Sangari, F. J., “Mycobacterial invasion of epithelial cells.”, Sub-cellular biochemistry, vol. 33, pp. 231-49, 2000.

F. J. Sangari, Goodman, J., and Bermudez, L. E., “Mycobacterium avium enters intestinal epithelial cells through the apical membrane, but not by the basolateral surface, activates small GTPase Rho and, once within epithelial cells, expresses an invasive phenotype.”, Cellular microbiology, vol. 2, no. 6, pp. 561-8, 2000.

E. C. Miltner and Bermudez, L. E., “Mycobacterium avium grown in Acanthamoeba castellanii is protected from the effects of antimicrobials.”, Antimicrobial agents and chemotherapy, vol. 44, no. 7, pp. 1990-4, 2000.

T. Bodmer, Miltner, E., and Bermudez, L. E., “Mycobacterium avium resists exposure to the acidic conditions of the stomach.”, FEMS microbiology letters, vol. 182, no. 1, pp. 45-9, 2000.

A. E. Parker and Bermudez, L. E., “Sequence and characterization of the glyceraldehyde-3-phosphate dehydrogenase of Mycobacterium avium: correlation with an epidermal growth factor binding protein.”, Microbial pathogenesis, vol. 28, no. 3, pp. 135-44, 2000.

F. J. Sangari, Goodman, J. R., and Bermudez, L. E., “Ultrastructural study of Mycobacterium avium infection of HT-29 human intestinal epithelial cells.”, Journal of medical microbiology, vol. 49, no. 2, pp. 139-47, 2000.

L. E. Bermudez, Parker, A., and Petrofsky, M., “Apoptosis of Mycobacterium avium-infected macrophages is mediated by both tumour necrosis factor (TNF) and Fas, and involves the activation of caspases.”, Clinical and experimental immunology, vol. 116, no. 1, pp. 94-9, 1999.

L. E. Bermudez, Sangari, F. J., and Parker, A., “Green fluorescent protein in the measurement of bacteria-host interactions.”, Methods in enzymology, vol. 302, pp. 285-95, 1999.

L. E. Bermudez and Petrofsky, M., “Host defense against Mycobacterium avium does not have an absolute requirement for major histocompatibility complex class I-restricted T cells.”, Infection and immunity, vol. 67, no. 6, pp. 3108-11, 1999.

J. D. Cirillo, Cirillo, S. L., Yan, L., Bermudez, L. E., Falkow, S., and Tompkins, L. S., “Intracellular growth in Acanthamoeba castellanii affects monocyte entry mechanisms and enhances virulence of Legionella pneumophila.”, Infection and immunity, vol. 67, no. 9, pp. 4427-34, 1999.

L. E. Bermudez, Wu, M., Miltner, E., and Inderlied, C. B., “Isolation of two subpopulations of Mycobacterium avium within human macrophages.”, FEMS microbiology letters, vol. 178, no. 1, pp. 19-26, 1999.

L. E. Bermudez, Kolonoski, P., Wu, M., Aralar, P. A., Inderlied, C. B., and Young, L. S., “Mefloquine is active in vitro and in vivo against Mycobacterium avium complex.”, Antimicrobial agents and chemotherapy, vol. 43, no. 8, pp. 1870-4, 1999.

F. J. Sangari, Petrofsky, M., and Bermudez, L. E., “Mycobacterium avium infection of epithelial cells results in inhibition or delay in the release of interleukin-8 and RANTES.”, Infection and immunity, vol. 67, no. 10, pp. 5069-75, 1999.

F. J. Sangari, Parker, A., and Bermudez, L. E., “Mycobacterium avium interaction with macrophages and intestinal epithelial cells.”, Frontiers in bioscience : a journal and virtual library, vol. 4, pp. D582-8, 1999.

M. Petrofsky and Bermudez, L. E., “Neutrophils from Mycobacterium avium-infected mice produce TNF-alpha, IL-12, and IL-1 beta and have a putative role in early host response.”, Clinical immunology (Orlando, Fla.), vol. 91, no. 3, pp. 354-8, 1999.

L. E. Bermudez, Goodman, J., and Petrofsky, M., “Role of complement receptors in uptake of Mycobacterium avium by macrophages in vivo: evidence from studies using CD18-deficient mice.”, Infection and immunity, vol. 67, no. 9, pp. 4912-6, 1999.

L. E. Bermudez, Petrofsky, M., Wu, M., and Young, L. S., “Clarithromycin significantly improves interleukin-12-mediated anti-Mycobacterium avium activity and abolishes toxicity in mice.”, The Journal of infectious diseases, vol. 178, no. 3, pp. 896-9, 1998.

L. E. Bermudez, Petrofsky, M., Kolonoski, P., and Young, L. S., “Emergence of Mycobacterium avium populations resistant to macrolides during experimental chemotherapy.”, Antimicrobial agents and chemotherapy, vol. 42, no. 1, pp. 180-3, 1998.

J. A. Maddry, Bansal, N., Bermudez, L. E., Comber, R. N., Orme, I. M., Suling, W. J., Wilson, L. N., and Reynolds, R. C., “Homologated aza analogs of arabinose as antimycobacterial agents.”, Bioorganic & medicinal chemistry letters, vol. 8, no. 3, pp. 237-42, 1998.